Natalizumab is Effective for the Treatment of Relapsing-remitting Tumefactive Multiple Sclerosis

We herein report the case of a 57-year-old woman presenting with a biopsy-proven tumefactive demyelinating lesion as her first clinical event. Subsequently, she displayed a relapsing-remitting course with recurrence of large demyelinating lesions exceeding 2 cm in diameter rather than the small ovoi...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakamura, Masataka, Itani, Kumi, Miyake, Kousuke, Kunieda, Takenobu, Kaneko, Satoshi, Kusaka, Hirofumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337470/
https://www.ncbi.nlm.nih.gov/pubmed/28090055

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337470/
https://www.ncbi.nlm.nih.gov/pubmed/28090055

Ejemplares similares